An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

Gilgamesh Pharma, a clinical-stage neuroscience company focused on transforming psychiatric treatment, today announced positive topline results from its Phase 2a study of blixeprodil (GM-1020).

Please provide your email address to receive an email when new articles are posted on . Spravato is the first monotherapy for adults with major depressive disorder who had an inadequate response to at ...

Until recently, clinical depression treatments have fallen into just two categories: psychotherapy and antidepressant medications. But this year, the U.S. Food and Drug Administration cleared the ...

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...

Treatment-resistant depression (TRD) occurs when major depressive disorder (MDD) treatment does not work. There is no official definition or set criteria for TRD, but the measure often used is an ...

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...

Fish oil pills rich in omega-3 fatty acids gained attention as a possible add-on treatment for depression, as a few studies ...